January 4, 20101NeoPharm to Investigate Treatment for Deadly Lung Disease The drug candidate IL13-PE has the potential to be the first effective therapy for idiopathic pulmonary fibrosis (IPF), which kills an estimated 40,000 people in the United States each year.
